feed,title,long_url,short_url
Benzinga,"Galapagos' Another Psoriasis Candidate Shows Efficacy, Safety Profile In Mid-Stage Study",https://benzinga.com/general/biotech/21/07/21992731/galapagos-another-psoriasis-candidate-shows-efficacy-safety-profile-in-mid-stage-study,https://j.mp/2UIC2iS
Benzinga,"Galapagos Shares Drop As SIK Inhibitor Fails To Show Positive Outcomes In Ulcerative Colitis, Rheumatoid Arthritis Patients",https://benzinga.com/general/biotech/21/07/21992730/galapagos-shares-drop-as-sik-inhibitor-fails-to-show-positive-outcomes-in-ulcerative-colitis-rheu,https://j.mp/3hF2PWk
